Crowdberry
VC Fund
Bratislava, Slovakia (Slovak Republic)
Crowdberry is a VC fund in Bratislava focused on Health Diagnostics and SaaS. Crowdberry is the first Czecho - Slovak crowd-investing platform helping Czech and Slovak companies to get growth capital and new investors. Our mission is to connect innovative, yet proven and growing businesses with a wider group of private and professional investors (Crowdberry crowd). We enable direct investments in unique and growingbusinesses. We strive to help our investors not only to get capital returns but enable them to own a share of a company based on their preferences. Our investors are often engaged with the business owners and help them succeed through their experience, knowledge and network. The main difference from a typical crowdfunding portal or investment company is the Crowdberry investment process itself and the smart capital we strive to acquire. Each company shall pass our due diligence process in order to get access to our Crowdberry crowd. A structured pre-selection and consulting process by an internationally experienced Crowdberry investment team enables us to prepare a tailor made investment set-up and structure for any business model or industry.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Crowdberry invests in
Stages Crowdberry invests in
Countries Crowdberry invests in
Round sizes
Round size
- Seed
- $1.1M–$9.5M
- Series A
- $6.6M–$6.7M
Investment Focus
Industry
- Health Diagnostics 2 (29%)
- SaaS 1 (14%)
- Finance 1 (14%)
- Fitness 1 (14%)
- Big Data 1 (14%)
Stage
- Seed 2 (29%)
- Series A 2 (29%)
- Funding Round 1 (14%)
- Venture - Series Unknown 1 (14%)
Country
- Slovakia (Slovak Republic) 3 (43%)
- Germany 1 (14%)
- United States 1 (14%)
- Czech Republic 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NEXINEO delivers comprehensive services to end users (individual design, implementation, and service). We understand that "the best advertising is a satisfied customer," which is the company's entire philosophy. | $1.4M / Venture - Series Unknown / Jun 27, 2023 | ||
| Sensoneo is a global enterprise-grade smart waste management solution provider that enables cities and businesses to manage their waste cost-efficiently, be more environmentally responsible and improve the well-being of people. Through its unique smart waste management technology, Sensoneo is redefining the way waste is managed. The solutioncombines unique ultrasonic Smart Sensors (Single, Double, Quatro and patent-pending Micro-sensors) that monitor waste real-time with sophisticated software (Smart Analytics, Smart Route Planning and Smart Waste Management System) providing cities and businesses with data-driven decision making, and optimization of waste collection routes, frequencies and vehicle load. This results in overall waste collection cost reduction of at least 30% and carbon emission reduction up to 60% in cities. Sensoneo smart waste management has attracted cities and business around the world and the solution is installed in numerous locations across Europe, North America, South America, Middle East, Australia and New Zealand. For more information about how Sensoneo can help you manage your waste smarter, please visit www.sensoneo.com. | $6.7M / Series A / Jun 08, 2023 | ||
| Digitoo is on the mission to free accountants of the manual and repetitive work they go through on a daily basis. And in turn help them focus on more creative activities with business impact.Accounting is a universal need for managing businesses of all sizes and for compliance. Ever since accounting software was born, subsequent automation hasbeen largely restricted to custom applications built on top and around accounting software for large enterprises. These help with document exchange (EDI), data capture, and connect the many workflows between a trade document being received/issued and payment. For most part, SMEs (and not just the tiny ones!) and their accounting providers have been left behind. Looking at the accounting cycle, there are large gaps in workflows filled with manual work where software should do the heavy lifting, and Digitoo will take care of it. | $1.1M / Seed / Nov 14, 2022 | ||
| Powerful Medical's PMcardio® is an AI-powered cardiovascular diagnostics and care coordination platform that transforms any 12-lead ECG—paper, scan, image, or digital—into an instant, expert-level diagnostic tool on any smartphone or computer. Powered by Queen of Hearts™, our FDA breakthrough-designated STEMI detection model, PMcardioidentifies true STEMI and STEMI-equivalent patterns with far greater accuracy than traditional criteria. Already used by 100,000 clinicians and detecting 36,000 heart attacks in H1/25 alone, PMcardio has been recognized as a strategic EU priority with a $46M non-dilutive R&D grant, and we are now seeking a $25M partner to commercialize in the U.S.Trained on 2.5 million clinically validated ECGs and proven in 15+ clinical studies, Queen of Hearts™ delivers twice the sensitivity for early STEMI detection and reduces false positives by 90%, cutting door-to-balloon times by an average of 48 minutes. PMcardio closes critical diagnostic gaps—especially in non-PCI and rural settings—ensuring faster, more accurate triage and timely access to life-saving PCI therapy.Powerful Medical has been recognized by the AHA, Google for Startups, and has won the 2025 MedTech Innovator Program! | $9.5M / Seed / Sep 28, 2022 | ||
| NEXINEO delivers comprehensive services to end users (individual design, implementation, and service). We understand that "the best advertising is a satisfied customer," which is the company's entire philosophy. | Venture - Series Unknown / Apr 23, 2021 | ||
| GymBeam is a health and fitness company specializing in a wide variety of sports nutrition, healthy foods, activewear, and workout accessories. Through its direct-to-consumer e-commerce platform, the company serves millions of customers across numerous countries with a broad range of products designed for athletes and wellness-focused consumers.GymBeam also invests in product development, manufacturing, logistics, and digital innovation to deliver quality, convenience, and an improved customer experience. | $6.6M / Series A / May 27, 2020 | ||
| MultiplexDX is a biotech diagnostics company, developing accurate, specific, quantifiable, and affordable diagnostic tests. It aims to provide effective and successful treatment of tumors and prevent cancer. To achieve this, the company is in the phase of developing a new visualization technology combining the approach of molecular biology andhistopathological methods. This technology has an ambition to surpass the limitations of existing medical diagnostic and prognostic methods and to take a key role in this fast-changing market.MultiplexDX operates from Kosice, Slovakia and Maryland, US and is currently serving first clients on both European and US markets. | $1.4M / Oct 04, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Crowdberry invest in?
Crowdberry invests primarily in Health Diagnostics, SaaS and Finance startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Slovakia (Slovak Republic). The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Crowdberry's check size?
Crowdberry typically joins rounds of $1.1M–$9.5M at Seed and $6.6M–$6.7M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Crowdberry participates in.
When did Crowdberry last invest?
The most recent investment recorded for Crowdberry closed in Jun 2023. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
